Relating to: designating June 2025 as Myasthenia Gravis Awareness Month.
AJR 64 designates June 2025 as Myasthenia Gravis Awareness Month, boosting public knowledge and support for patients and families affected by this chronic condition.
AJR 64 designates June 2025 as Myasthenia Gravis Awareness Month, boosting public knowledge and support for patients and families affected by this chronic condition.
AJR 64 is a joint resolution introduced to designate June 2025 as Myasthenia Gravis Awareness Month. The intent of this resolution is to raise awareness about Myasthenia Gravis (MG), a chronic autoimmune neuromuscular disorder that affects communication between nerves and muscles, leading to varying degrees of weakness in voluntary muscles.
AJR 64 aims to enhance public awareness of Myasthenia Gravis by designating June 2025 as a month dedicated to education and advocacy. This resolution not only seeks to inform the community about the disorder but also aims to foster support for those affected by it. The successful passage of this resolution could lead to significant outreach and educational efforts surrounding Myasthenia Gravis.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.